Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 16;110(10):2879-2891.
doi: 10.1210/clinem/dgaf041.

The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study

Affiliations

The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study

Mandy Fisher et al. J Clin Endocrinol Metab. .

Abstract

Context: During pregnancy, women who experience certain pregnancy complications show elevations in biomarkers of inflammation and insulin resistance; however, few studies have examined these cardiometabolic biomarkers in the decade following pregnancy.

Objective: To examine the association between pregnancy complications and cardiometabolic biomarkers 9 years postpartum including blood pressure, blood lipids, body fat percentage, insulin resistance [glucose, insulin, proinsulin, C-peptide, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), glycated hemoglobin (HbA1c), leptin, adiponectin], and inflammation (high-sensitivity-C-reactive protein).

Methods: Using data from the Maternal-Infant Research on Environmental Chemicals cohort study (2008-2021), we determined 3 groups of pregnancy complications: (1) hypertensive disorders of pregnancy (HDP) (n = 35); (2) any pregnancy complication in the index pregnancy, defined as preterm birth, HDP, impaired glucose tolerance or gestational diabetes mellitus (n = 55); and (3) self-reported recurrence of 1 of these pregnancy complications (n = 19). Our comparison group included 186 women with uncomplicated pregnancies.

Results: In our adjusted linear regression results, all pregnancy complication groups showed significantly higher systolic and diastolic blood pressure 9 years later. HOMA-IR was 23% [95% confidence interval (CI): -4.4%, 57%], 26% (95% CI: 2.0%, 55%), and 51% (95% CI: 12%, 104%) higher at follow-up in participants who had experienced a prior HDP, an index pregnancy complication, or a recurrent pregnancy complication, respectively. Elevations were also seen with HbA1c, insulin, C-peptide, and leptin, especially among those with recurrent complications.

Conclusion: This study contributes to the body of evidence that women with a history of certain pregnancy complications merit special attention in the prevention of cardiovascular disease. We recommend further exploration into these associations in larger cohorts.

Keywords: cardiometabolic health; hypertensive disorders; pregnancy; recurrence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
VENN diagram of pregnancy complications in the MIREC index pregnancy (2008-2011). During the MIREC index pregnancy (2008-2011) 55 women had “any” pregnancy complication in the MIREC index pregnancy. There were 14 women who had gestational diabetes or impaired glucose tolerance, 16 preterm births, and 35 women experienced a HDP. Abbreviations: GDM, gestational diabetes mellitus; HDP, hypertensive disorders of pregnancy; IGT, impaired glucose tolerance; MIREC, Maternal-Infant Research on Environmental Chemicals.
Figure 2.
Figure 2.
VENN diagram of recurrent pregnancy complications. Because women gave information on their obstetrical history in the MIREC ENDO follow-up visit approximately 9 years postpartum, we obtained self-reported information on all of their pregnancies. A total of 95 (36 + 14 + 26 + 11 + 4 + 4 = 95) participants had a pregnancy complication with their MIREC index child, previous to the MIREC index child (past pregnancy) or after the MIREC index child (future pregnancy). Nineteen women reported recurring pregnancy complications: 11 women had a complication in a past pregnancy and the MIREC index pregnancy, 4 had a pregnancy complication in MIREC and then again in the future, and another 4 women had a pregnancy complication in a past pregnancy, the MIREC index pregnancy, and a future pregnancy. Abbreviations: MIREC, Maternal-Infant Research on Environmental Chemicals.
Figure 3.
Figure 3.
MIREC-ENDO clinic visit participation. Note that 49 participants were excluded from the “Uncomplicated Pregnancies” group because they had self-reported a pregnancy complication prior to (n = 26) or after (n = 14) the MIREC index pregnancy but not in the MIREC index pregnancy (see Fig. 2) or they were missing pregnancy complication information in the MIREC index pregnancy (n = 2) or were diagnosed with chronic HTN during the MIREC index pregnancy (n = 7). 186 (uncomplicated) + 55 (pregnancy complications) + 49 (described earlier) = 290. Abbreviations: BP, blood pressure; GDM, gestational diabetes mellitus; HTN, hypertension; MIREC, Maternal-Infant Research on Environmental Chemicals.

References

    1. Norris CM, Yip CYY, Nerenberg KA, et al. State of the science in Women's cardiovascular disease: a Canadian perspective on the influence of sex and gender. J Am Heart Assoc. 2020;9(4):e015634. - PMC - PubMed
    1. Wu P, Park K, Gulati M. The fourth trimester: Pregnancy as a predictor of cardiovascular disease. Eur Card Rev. 2021;16:e31. - PMC - PubMed
    1. Minissian MB, Kilpatrick S, Eastwood JA, et al. Association of spontaneous preterm delivery and future maternal cardiovascular disease. Circulation. 2018;137(8):865‐871. - PMC - PubMed
    1. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev. 2014;36(1):57‐70. - PMC - PubMed
    1. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1‐19. - PubMed